Endpoints News ٣٠ ديسمبر ٢٠٢٥ Verastem axes Phase 1/2 lung cancer trial of Avmapki, pivots to KRAS blocker
Endpoints News ٢٩ ديسمبر ٢٠٢٥ Federal judge blocks 340B drug pricing pilot ahead of Jan. 1 effective date
Endpoints News ٢٩ ديسمبر ٢٠٢٥ ASK Pharm makes China rights deal; Unicycive resubmits kidney drug after CRL
Endpoints News ٢٩ ديسمبر ٢٠٢٥ As gene editing tools multiply, the hunt for the final technology continues
Endpoints News ٢٦ ديسمبر ٢٠٢٥ Biohaven’s ion channel drug fails again, this time in major depressive disorder
Endpoints News ٢٤ ديسمبر ٢٠٢٥ Sanofi to buy hepatitis B vaccine maker Dynavax for $2.2B; gets CRL for MS drug
Endpoints News ٢٣ ديسمبر ٢٠٢٥ Labcorp backs Cellens in developing physics test aimed at bladder cancer
Endpoints News ٢٣ ديسمبر ٢٠٢٥ Neurocrine’s Ingrezza flunks pivotal study in dyskinetic cerebral palsy